(NYSE:RMD),(AUST:RMD.AX), SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss […]
(NASDAQ:SYRE), WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease and rheumatic diseases, today announced that Spyre's independent Compensation Committee of the Board of Directors approved the
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium Presentation GlobeNewswire January 08, 2026 HOUSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of
ClinNEXUS Launches New Corporate Rebranding to Kick Off Attendance During Week of J.P. Morgan Healthcare Conference GlobeNewswire January 08, 2026 -Updated logo and website better reflect patient-centric focus and accessibility as well as new inflection point for company- -ClinNEXUS management will be in attendance during “JPM Week” hosting investor meetings and sharing its new corporate
Treace Announces First Surgical Case Utilizing Lapiplasty(R) Lightning(TM) Technology GlobeNewswire January 08, 2026 PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion
Cipher Mining Announces Participation in Upcoming Investor and Industry Conferences GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a leader in the development of industrial-scale data centers, today announced its participation in several upcoming industry conferences. Cipher's CEO, Tyler Page, may be
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 GlobeNewswire January 08, 2026 PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced preliminary, unaudited sales results
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook GlobeNewswire January 08, 2026 Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive preliminary results from first six patients with type 1 diabetes treated with tegoprubart following islet transplantation in
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance GlobeNewswire January 08, 2026 International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock New Market Opportunity
Preferred Bank Announces 2025 Fourth Quarter Earnings Release and Conference Call GlobeNewswire January 08, 2026 LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in California, today announced plans to release its financial results for the fourth quarter ended December 31, 2025 before the open